Chris Lorson, University of Missouri-Columbia (IMAGE)

University of Missouri-Columbia

Chris Lorson, University of Missouri-Columbia

Caption

Lorson and his team are studying a subtype of SMA, spinal muscular atrophy with respiratory distress type 1, and have developed a gene replacement therapy that can be used to treat and control the disease in the future.

Credit

Chris Lorson

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.